The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Serov D.N.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii DZM

Minkina O.V.

Moskovskiĭ nauchno-prakticheskiĭ Tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia

Topical therapy for atopical dermatitis under the present conditions

Authors:

Potekaev N.N., Serov D.N., Minkina O.V.

More about the authors

Read: 985 times


To cite this article:

Potekaev NN, Serov DN, Minkina OV. Topical therapy for atopical dermatitis under the present conditions. Russian Journal of Clinical Dermatology and Venereology. 2012;10(5):58‑64. (In Russ.)

Recommended articles:
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Asse­ssment of the serum inte­rleukin 33 (IL-33) level in patients with atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):293-296
Gene­sis of emollients. Past, present, future. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):412-420
From atopy to infe­ction — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):430-436
Clinical case of nevoid hype­rkeratosis of the nipple-areola complex. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):537-540
Atopic dermatitis: the problem of adhe­rence to emollients. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):698-707
Issues of diagnosis and treatment of atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):838-845
Mechanisms of addi­tivity of physiotherapeutic factors in complex therapy of poly­pous rhinosinusitis complicated by como­rbidities. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):5-11

References:

  1. Leung D.Y., Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160.
  2. Atopicheskii dermatit. Novye podkhody k profilaktike i lecheniyu. Rekomendatsii dlya praktikuyushchikh vrachei. Pod red. Yu.V. Sergeeva. M: Meditsina dlya vsekh 2003; 46.
  3. Grebenyuk N.V. Progress v naruzhnoi kortikosteroidnoi terapii atopicheskogo dermatita u detei. Pediatriya 1998; 5: 88-91.
  4. Organizatsiya spetsializirovannoi meditsinskoi pomoshchi detyam, bol'nym atopicheskim dermatitom. Metodicheskie rekomendatsii. Pod red. N.G. Korotkogo. Ekaterinburg 2011.
  5. Baranov A.A., Khaitov R.M. Allergologiya i immunologiya: klinicheskie rekomendatsii dlya pediatrov. M: Izd-vo "Soyuz pediatrov Rossii" 2011; 15-75.
  6. Sawada S., Suzuki G., Kawase Y., Takaku F. A novel immunosuppressive agent, FK-506. In vitro effects on the cloned T-sell activation. J Immunol 1987; 139: 1797-1803.
  7. Tocci M.J., Matkovich D.A., Collier K.A. et al. The immunosuppressant FK-506 inhibits expression of early T-cell activation genes. J Immunol 1989; 143: 718-726.
  8. Balabolkin I.I. Atopicheskii dermatit. Pediatriya 2002; 5: 38-43.
  9. Kim M.B., Kim G.W., Park H.J. et al. Pimecrolimus 1% cream for the treatment of rosacea. Jap J Dermatol 2011; 38: 1135-1139.
  10. Aryaev N.L., Klimenko V.A., Kozhemyaka A.I., Feklin V.A. Atopicheskii dermatit v praktike pediatra. Kiev 2007; 88.
  11. Aalberse R.C., Akkerdaasjh, van Ree R. Cross-reactivity of IgE antibodies to allergens. J Allergy Clin Immunol 2001; 56: 809.
  12. Sulzberger M.B., Witten V.H. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 1952; 19: 101-102.
  13. Rogers P.J., Wood S.M., Garrett E.L. et al. Use of nonprescription topical steroids: patients' experiences. Br J Dermatol 2005; 152: 6: 1193-1198.
  14. Akdis C., Akdis M., Bieber T. et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology /PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 1: 152-169.
  15. Leung D.Y.M., Gong J.Q. et al. J Allergy Clin Immunol 2000; 45: 41-50.
  16. Ring J., Abeck D., Neuber K. Atopic Eczema. Role of Microorganisms on the Skin Surface Source. J Allergy Clin Immunol 1992; 47: 265-269.
  17. Sovremennaya strategiya terapii atopicheskogo dermatita: programma deistvii pediatra. Soglasitel'nyi dokument Assotsiatsii detskikh allergologov i immunologov Rossii. M 2004.
  18. Smirnova G.I. Atopicheskii dermatit. M 2004.
  19. Mokronosova N.A., Maksimova A.E., Baturo A.T. i dr. Znachenie kolonizatsii kozhi Staphylococcus aureus dlya differentsial'noi diagnostiki atopicheskogo dermatita. Vestn dermatol i venerol 1997; 5: 37-39.
  20. Bunikowski R., Mielke M., Skarabis H. et al. Evidence for a disease promoting effect of S aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000; 105: 814-819.
  21. Kostrykina L.N., Ivanova N.A., Shabalov N.P. Kliniko-anamnesticheskie i laboratornye osobennosti atopicheskogo dermatita u detei s retsidiviruyushchimi infektsiyami kozhi i podlezhashchikh tkanei. Dermatologiya 2007; 8: 337-348.
  22. Kaznacheeva L.F., Molokova A.V., Kaznacheev K.S. Profilaktika vtorichnogo infitsirovaniya kozhi u detei s atopicheskim dermatitom. Ratsional'naya terapiya i ukhod. Ros allergol zhurn 2005; 3: 82-86.
  23. Denby K.S., Beck L.A. Update on systemic therapies for atopic dermatitis. Cur Opin Allergy Clin Immunol 2012; 12: 4: 421-426.
  24. Garnacho-Saucedo G., Salido-Vallejo R., Moreno-Gimenez J.C. Atopic dermatitis: Update and Proposed Management Algorithm. Actas Dermosifiliogr 2012; 10.
  25. Lee S.I., Kim J., Han Y., Ahn K. A proposal: Atopic Dermatitis Organizer (ADO) guideline for children. Asia Pacific Allergy 2011; 1: 53-63.
  26. Kay J., Gawkrodger D.J., Mortimer M.J., Jaron A.G. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30: 35-39.
  27. Besnier E. Premiere note et observations preliminaires pour servir introduction aletude diatesique (in French). Ann Detmatol Syphil 1992; 4: 634.
  28. Novak N., Bieber T. Pathophysiologie der atopischen Dermatitis. Deutsches Ärzteblatt 2004; 101: 3: 108-120.
  29. Wise F., Sulzberger M.B. Editorial remarks. Year Book of Dermatology and Syphilology. Year Book Medical 1993; 59.
  30. Borelli S. Psyche und Haut. Handbuch der Haut-und Geschlechtskrankheiten, Erganzungswerk. Ed. J. Jadassohn. Berlin: Springer-Verlag - New York: Heidelberg 1997; 8: 264-571.
  31. Miyadoh S. Atlas of Actynomycetes. Yokohama: Asakura Publishing Co 1997.
  32. Mincer T.J., Jensen P.R. Kauffman C.A., Fenical W. Widespread and persistent populations of a major new marine actinomycete taxon in oceansediments. Appl Environ Microbiol 2002; 68: 10: 5005-5011.
  33. Kurtboke D.I., Hayakawa M., Terekhova L., Okazaki T. Selective isolation of rare actinimycetes. Ed. I. Kurtboke. Quinsland (Australia): Univ Sunshine Coast 2003.
  34. Jensen P., Dwight R., Fenical W. Distribution of actinomycetes in near-shore tropical marine sediments. Appl Environ Microbiol 1991; 54: 1102-1108.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.